4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-016279
CHIEF OPERATING OFFICER sold 1,133 shares at $20.06 ($22,722)
- CHIEF OPERATING OFFICER acquired 1,133 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,133 | $2.48 | $2,810 | 1,133 | D |
| 2024-06-06 | Sale : show line 2 in the form 10b5-1 | −1,133 | $20.06 | $22,722 | 0 | D |
| Open-market sales · 1,133 sh · avg $20.06 · $22,722 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-06 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) | −1,133 | 53,342 | D |
Loading xslF345X05/form4-06102024_100635.xml…